MedWatch

Lundbeck drug hope moves closer to moment of truth

This quarter, pharmaceutical company Lundbeck will deliver crucial results for Rexulti in a new indication. The market awaits the news with anticipation, since share prices could skyrocket.

Lundbeck CEO Deborah Dunsire | Photo: Gregers Tycho/ERH

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list Hear.com, which handles online sales.

Further reading

Related articles

Latest news

See all jobs